HRA005932
Title:
Comprehensive fragmentation of cell-free repetitive DNA for enhanced cancer detection in plasma
Release date:
2024-11-10
Description:
we present our findings on the utility of fragmentomic profiles of cfRE (cfRE-F) for detecting multicancer through low-pass whole genome sequencing (lpWGS). our study provides a framework for analyzing the genomic signature of cfRE fragments in plasma that can be used for sensitive, robust, and cost-effective tumor detection and localization.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Cohort Study
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Chosenmed Medical DAC
Contact person:
Wang Dongliang
Email:
dongliangwang@chosenmedtech.com
Description:
be responsible to data management and review
Individuals & samples
Submitter:   Wang Dongliang / dongliangwang@chosenmedtech.com
Organization:   Chosenmed
Submission date:   2023-11-02
Requests:   -